These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10640762)

  • 1. IL-13 is a susceptibility factor for Leishmania major infection.
    Matthews DJ; Emson CL; McKenzie GJ; Jolin HE; Blackwell JM; McKenzie AN
    J Immunol; 2000 Feb; 164(3):1458-62. PubMed ID: 10640762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling.
    Nishikomori R; Gurunathan S; Nishikomori K; Strober W
    J Immunol; 2001 Jun; 166(11):6776-83. PubMed ID: 11359836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
    Jones DE; Buxbaum LU; Scott P
    J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
    Padigel UM; Farrell JP
    J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major.
    Dent AL; Doherty TM; Paul WE; Sher A; Staudt LM
    J Immunol; 1999 Aug; 163(4):2098-103. PubMed ID: 10438949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
    Erb KJ; Blank C; Moll H
    Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
    Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
    J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.
    Himmelrich H; Launois P; Maillard I; Biedermann T; Tacchini-Cottier F; Locksley RM; Röcken M; Louis JA
    J Immunol; 2000 May; 164(9):4819-25. PubMed ID: 10779790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice.
    Nigg AP; Zahn S; Rückerl D; Hölscher C; Yoshimoto T; Ehrchen JM; Wölbing F; Udey MC; von Stebut E
    J Immunol; 2007 Jun; 178(11):7251-8. PubMed ID: 17513774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
    Anderson CF; Mendez S; Sacks DL
    J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development.
    Güler ML; Gorham JD; Hsieh CS; Mackey AJ; Steen RG; Dietrich WF; Murphy KM
    Science; 1996 Feb; 271(5251):984-7. PubMed ID: 8584935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
    Heinzel FP; Maier RA
    Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.
    Barbi J; Brombacher F; Satoskar AR
    J Immunol; 2008 Oct; 181(7):4613-20. PubMed ID: 18802063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early IL-4 production does not predict susceptibility to Leishmania major.
    Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
    Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 is required to maintain a Th1 response during Leishmania major infection.
    Park AY; Hondowicz BD; Scott P
    J Immunol; 2000 Jul; 165(2):896-902. PubMed ID: 10878364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.
    Kropf P; Etges R; Schopf L; Chung C; Sypek J; Müller I
    J Immunol; 1997 Oct; 159(7):3434-43. PubMed ID: 9317142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major.
    Launois P; Conceiçao-Silva F; Himmerlich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA
    Parasite Immunol; 1998 May; 20(5):223-30. PubMed ID: 9651923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.